View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AA64 | Publication ID: Spring 2009 |
Title: Chemical Mixtures Containing Gamma-Butyrolactone | |
Abstract: In previous rulemakings, DEA made gamma-butyrolactone (GBL) a List I chemical and established thresholds for transactions involving this chemical. This rule establishes a concentration limit for chemical mixtures containing GBL. Currently, all chemical mixtures containing GBL are exempt from regulation. These mixtures will remain exempt until publication of a final rule. GBL is used in the illicit manufacture of gamma-hydroxybutyric acid (GHB), a Schedule I controlled substance. | |
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1310 | |
Legal Authority: 21 USC 802 21 USC 830 21 USC 871(b) |
Legal Deadline:
None |
|||||||||||||||||||||||||||
Timetable:
|
Additional Information: DEA-222 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
Public Comment URL: www.deadiversion.usdoj.gov | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 1117-AA31 | |
Agency Contact: Mark W. Caverly Chief, Liaison and Policy Section Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7297 Email: dea.diversion.policy@usdoj.gov |